Clinical trial
Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for…
NCT00412776 · Sesen Bio, Inc., Industry · Terminated
Key facts
| NCT number | NCT00412776 |
|---|---|
| Title | Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer |
| Official title | A Randomized, Multicentre Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Proxinium Plus Best Supportive Care Versus Best Supportive Care Alone in Patients With Advanced SCCHN Who Have Received at Least One Anti-cancer Treatment Regimen for Advanced Disease |
| Lead sponsor | Sesen Bio, Inc., Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Carcinoma, Squamous Cell of Head and Neck, Squamous Cell, Neoplasms, Head and Neck Neoplasms, Mouth Neoplasms, Head and Neck Cancer |
| Intervention type | Drug |
| Interventions | Proxinium |
| Enrollment | 165 |
| Start date | Dec 1, 2005 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Dec 18, 2006 |
| Last update posted | Dec 23, 2015 |
| Countries | Argentina, Brazil, Croatia, France, Germany, Hungary, India, Israel, Italy, Mexico, Poland, Romania and 6 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: